PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of oncotargetLink to Publisher's site
 
Oncotarget. 2016 August 23; 7(34): 54274–54289.
Published online 2016 August 2. doi:  10.18632/oncotarget.11026
PMCID: PMC5342341

Cardiac fibrosis in mouse expressing DsRed tetramers involves chronic autophagy and proteasome degradation insufficiency

Abstract

Proteinopathy in the heart which often manifests excessive misfolded/aggregated proteins in cardiac myocytes can result in severe fibrosis and heart failure. Here we developed a mouse model, which transgenically express tetrameric DsRed, a red fluorescent protein (RFP), in an attempt to mimic the pathological mechanisms ofcardiac fibrosis. Whilst DsRed is expressed and forms aggregation in most mouse organs, certain pathological defects are specifically recapitulated in cardiac muscle cells including mitochondria damages, aggresome-like residual bodies, excessive ubiquitinated proteins, and the induction of autophagy. The proteinopathy and cellular injuries caused by DsRed aggregates may be due to impaired or overburdened ubiquitin-proteasome system and autophagy-lysosome systems. We further identified that DsRed can be ubiquitinated and associated with MuRF1, a muscle-specific E3 ligase. Concomitantly, an activation of NF-κB signaling and a strong TIMP1 induction were noted, suggesting that RFP-induced fibrosis was augmented by a skewed balance between TIMP1 and MMPs. Taken together, our study highlights the molecular consequences of uncontrolled protein aggregation leading to congestive heart failure, and provides novel insights into fibrosis formation that can be exploited for improved therapy.

Keywords: protein aggregation, cardiac hypertrophy, fibrosis, heart failure, proteasome, Pathology Section

INTRODUCTION

Cardiac myocytes are terminally differentiated cells with limited capacity of regeneration, therefore particularly sensitive to any stress with the potential of myocyte loss. Excessive misfolded proteins or aggregates in cardiac myocytes are often discovered at late stages of common heart diseases including cardiac amyloidosis, pathologic hypertrophy and dilated/ischemic cardiomyopathies [15]. Defects in key components of protein quality control (PQC) systems and high expression of aggregation-prone proteins may overwhelm protein clearance systems, leading to further aggregations that elicit cellular stress and inflammation, myocyte deaths, and ultimately heart failure [68]. The deposits of fibrotic extracellular matrix (ECM) are induced by local immune cell activation and the process is tightly regulated by the balanced action of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) [913]. Although it is widely accepted that proteinopathy plays a significant role in the pathogenesis of heart failure, the mechanisms by which protein aggregates cause injuries in cardiac myocytes and induce interstitial fibrosis are still unclear.

Tetrameric DsRed, a mammalian derivative of red fluorescent protein (RFP) of the coral Discosoma, was generated originally for imaging applications, but later it was found toxic to cells when expressed in large amount and the underlying mechanisms were not extensively explored [14, 15]. Tg mouse expressing tetrameric DsRed was not previously feasible presumably due to the toxicity to embryonic stem cells [14, 15]. Here we report the Tg mouse that switches from expressing enhanced green fluorescent protein (EGFP) to expressing DsRed tetramers. Severe cardiovascular phenotypes were resulted in DsRed mice including lethal dilated heart failure and massive fibrosis at 5 months of age. Thus, we hypothesized that the aggregation of DsRed tetramers causes proteinopathy in cardiac myocytes that can potentially overwhelm normal PQC systems and result into hypertrophy and fibrosis. To define the abnormalities in protein clearance pathways, we investigated autophagosome lysosome system (ALS) and ubiquitin proteasome system (UPS) in affected hearts and studied the fibrosis pathways underlying the disease progression. Unlike models of proteinopathy containing a congenital defect of PQC components, DsRed mouse preserves intact PQC system, thus potentially suitable for studies aiming to elucidate mechanistic connection among protein clearance systems, proteinopathy, and cardiac fibrosis.

RESULTS

Tetrameric RFP expression results in heart failure in mice

We previously generated a Tg mouse model, in which the expression of EGFP coding sequence within a LoxP cassette was driven by a ubiquitous CAGGS promoter (Figure (Figure1A).1A). By crossing with a CAGGS-Cre mouse, the green CALELD mouse became a red mouse due to the expression of tetrameric DsRed protein (RFP) (Figure S1A). The RFP mice which do not carry Cre transgene were bred further to generate RFP homozygotes (RFP+/+), which can be distinguished from hemizygotes (RFP+/−) by RT-PCR (Figure S1B) and by visual inspection on red fluorescence of mouse skin or eyes. RFP+/+ or RFP+/− mice were not different from wild-type mice in development and breeding (Figure S1C). Although appearing normal initially, RFP+/+ mice started to develop respiration distress after 4 months of age. Female RFP+/+ mice died at 5 months on average, and the males died at around 7 months. RFP+/− mice have longer life spans, on average 12 months for females and 18 months for males (Figure (Figure1B).1B). After signs of labored breathing appear in moribund RFP mice, cardiac hypertrophy, large left atrium blockage and thrombosis, and lung edema were always observed in the autopsy of euthanized mice (Figure 1C, 1D, S3A,B). Heart weight/body weight (HW/BW) ratio or HW/tibia length (HW/TL) ratio was not increased in RFP+/+ mice at 2 months (Figure S2B,C), but significantly increased in waning mice at 5 months. Heart failure markers such as NPPB was significantly increased in left ventricle (LV) of RFP+/+ mice at 2 and 5 months and in RFP+/− mice at 5 and 12 months (Figure (Figure1D).1D). Because RFP mice remain normotensive (Figure S2D), hypertension was not involved in the hypertrophy of RFP mouse. These results indicate that hypertrophy and heart failure was caused by DsRed tetramers and the severity and the time to onset correlated to the DsRed expression level and ages. In contrast, CALELD+/+ mice, which express high level of EGFP, remained free of any cardiovascular symptom and lived for at least 30 months.

Figure 1
Heart failure in RFP Tg mice

DsRed tetramer aggregation in cardiac tissues

In RFP mouse heart sections the presence of diffused red dots, which were strongly stained by eosin in the cytoplasm of cardiac myocytes was noticed (Figure (Figure2A).2A). Inflammation was found at the surrounding of the cardiac myocytes containing the red dots. The strong eosin-stained cytoplasm was highly reactive to anti-DsRed antibody (Figure S4A). In both 2-month-old RFP+/+ and RFP+/− mouse hearts, immunofluorescence with anti-DsRed antibody revealed large RFP clusters which corresponded to red dots in H&E. Many cardiac myocytes of RFP+/+ heart also contained diffused and smaller RFP patches in addition to large clusters, and these small RFP patches were rarely observed in RFP+/− heart (Figure (Figure2B).2B). This indicates when expressed in low to medium amount as in RFP+/− heart, RFP tends to form large clusters. When expressed in high amount as in RFP+/+ heart, small RFP patches appeared in cardiac myocytes in addition to large clusters. To study RFP forming aggregates or oligomers in mouse heart, LV tissue lysates were analyzed by native electrophoresis followed by immunoblotting to reveal the aggregation and the protein identity. The ladder-like protein bands were reactive to DsRed antibody, and the lowest molecular weight (MW) and each step of protein ladder was about 110 kDa, the predicted MW of a DsRed tetramer (Figure (Figure2C).2C). RFP+/− heart contained less RFP oligomers than the RFP+/+ heart, and the amount of aggregates did not increase with aging. Even in failing RFP+/− heart at 12 months, the RFP+/− aggregates remain not further increased, suggesting that the heart failure may result equally from failed compensation or remodeling and from excessive RFP oligomers. Many large RFP clusters were found at the vicinity of Z-lines, which was stained by connexin 43 (Figure (Figure2D),2D), suggests that DsRed tetramers and high order oligomers may impair cardiomyocyte contractility.

Figure 2
DsRed expression resulted in aggregation and cardiac myopathy

Impaired protein degradation systems in RFP mouse heart

Microstructure of LV of 5-month-old RFP+/+ mouse revealed disarrayed myofibrils with damaged and disintegrated mitochondrion in addition to many residual bodies and vacuoles found between muscle filaments (Figure (Figure3A).3A). These residual bodies are likely part of lysosomal organelles and autophagic vacuoles that are enclosed by the typical double membranes and contained engulfed mitochondrion and cytoplasmic material. We also observed inflammatory cells engulfing residual bodies, vacuoles, and debris (Figure (Figure3A).3A). Because the electron microscopic result showed excessive autophagic vacuoles and lysosomes in failing cardiac tissue, we studied the expression profile of genes that were significantly altered from age-matched wild-type mouse and are relating to autophagy, unfolded protein response (UPR) and ubiquitin pathways (Figure S4B,C). We assumed that a mild increase or decrease in gene expression in 2-month-old RFP+/+ mice followed by a greater change in 5-month-old RFP+/+ mice would indicate the altered gene expression correlating to the severity of phenotypes, thus more likely to be the primary gene response to RFP expression. The genes relating to ubiquitin pathways, including ubiquitin-activating enzymes ubiquitin ligases of E3 (), were increased in the RFP mouse heart. E3) and Lys-63-specific deubiquitinase () were decreased (Figure S4B). The genes including p62/SQSTM1, ATG4C, RGS19 and DRAM1 were increased, and ATG9A was decreased in the RFP mouse heart (Figure S4C). The genes relating to UPRDnaJ which is related to protein folding and endoplasmic reticulum-related genes including ERO1L, ERO1LB, SERP1, DNAJC10, EDEM1 were increased in RFP mice at late stage, but HSPA1l and RNF5, which also plays a key role in protein ubiquitination was reduced (Figure S4B). The protein level of Grp78, markers of ER stress, was increased in RFP mouse (Figure (Figure4A),4A), indicating the elevated ER stress may be involved.

Figure 3
Microstructure defects in RFP mouse heart
Figure 4
UPS involved in RFP degradation

To clarify mechanisms behind early pathological changes leading to myocyte injury, we focused on 2-month-old mice before phenotypes of the later stage occurred. An increase of LC3-I and LC3-II was observed in CALELD, RFP+/−, or RFP+/+ hearts, and LAMP1 was increased in RFP hearts. Further, p62 was strongly induced only in RFP+/+ heart but not in others (Figure (Figure3B).3B). These results suggest that autophagy flux may be altered in RFP+/+ heart. The increased autophagosome-like organelles and increased LC3-II would indicate the likelihood of enhanced autophagy flux, while the accumulation of ubiquitinated proteins and p62/LC3 induction (Figure (Figure4A)4A) were consistent to phenotypes caused by an inhibition of autophagy pathway. Thus, we studied the autophagy flux in RFP heart by injecting mice with chloroquine that would block lysosomal degradation [16] and with monodansylcadaverine (MDC), a fluorescent dye for endosome, autophagosome and lysosome [16, 17]. Chloroquine injection to RFP mouse led to a reduction of p62 and LC3-I and -II (Figure (Figure3C).3C). This result was validated by immunofluorescence staining showing decreased p62 and LC3 labeling in chloroquine-injected RFP mouse heart (Figure S5). In contrast, the intensity of MDC staining and the MDC-stained vacuoles were slightly increased by chloroquine (Figure S5). The result of p62 and LC3 response to chloroquine suggests that RFP+/+ heart was likely under chronic ALS inhibition. Double staining revealed that LC3B- and p62-labelled vacuoles or dots often colocalize with large RFP clusters (Figure (Figure3D),3D), indicating that RFP degradation involves both LC3 and p62. To study RFP in lysosomes, we used the isolated skeletal myoblasts from RFP mouse to investigate intracellular distribution of RFP with the lysotracker, and discovered RFP unequivocally colocalized with lysotracker (Figure S4D). Although in heart sections we failed to find large RFP clusters as part of lysosomal structures (Figure (Figure3D),3D), at least RFP can be located in the lysosome compartments in cultured myoblasts thus likely is degraded by ALS.

Hallmarks of proteinopathy in the cell include an accumulation of ubiquitinated proteins. Levels of ubiquitinated proteins in RFP+/− or CALELD mouse heart were not different from wild-type mouse, while the accumulation of ubiquitinated proteins was found in RFP+/+ heart (Figure (Figure4A).4A). Immunostaining revealed the majority of ubiquitinated proteins colocalized with large RFP clusters (Figure (Figure4D).4D). The expression of MuRF1 increased in CALELD and RFP+/+ mouse heart, and the MuRF1 staining showed some but not all MuRF1 colocalized with RFP (Figure (Figure4A).4A). One subunit of 20S proteasome, 20SX(β5), significantly increased only in RFP+/+ heart, and the staining showed the proteasomes at the predicated perinuclear locations, and were also colocalized with large RFP clusters (Figure (Figure4D).4D). These findings indicate that RFP may be ubiquitinated in cardiac tissue and cleared by UPS. We found in the heart lysate that RFP is ubiquitinated and physically associates with MuRF1 by immunoprecipitation and immunoblotting (Figure (Figure4B).4B). Although RFP expression in RFP+/+ heart lysate was significantly greater than in RFP+/− heart, the amount of ubiquitinated RFP in RFP+/− and RFP+/+ hearts were interestingly similar, indicating possibly a fixed ubiquitination capacity in cardiac tissues available for degrading RFP. Further, we measured the proteasome activity in LV and found the proteasome activity significantly increased in RFP hearts (Figure (Figure4C4C).

DsRed aggregates result in cardiac interstitial fibrosis

Continuous expression of DsRed tetramers in RFP mice led to extensive fibrosis in late-stage hypertrophied RFP hearts, in contrast to an absence of hypertrophy or fibrosis in CALELD mouse (Figure (Figure5A).5A). In other experimental models most fibrotic lesions occurred at endocardium, epicardium, and perivascular regions [1820]. In addition to those lesion-prone areas, fibrotic deposits in RFP mouse occurred predominantly at the myocardium. Genes relating to tissue remodeling and fibrosis were highly induced in RFP mice, including TIMP1, MMP2, MMP9, COL1A2, COL3A1, COL8A1 and COL14A1 (Figure (Figure5B).5B). COL1A1, an important marker for cardiac hypertrophy and pathological remodeling, increased significantly in RFP heart (Figure S6A). Besides TIMP1 gene induction, TIMP1 proteins increased significantly in young RFP heart (Figure (Figure5C)5C) and were located within cardiac myocytes and extracellularly (Figure (Figure5D,5D, S6B). The staining for reactive oxygen species (ROS) strongly increased in LV of RFP+/+ mouse at 5 months (Figure (Figure5E),5E), but similar ROS induction was not detected in 2-month-old RFP+/+ or RFP+/− heart (data not shown), suggesting that ROS which is primarily caused by mitochondrial dysfunction may not play the most important role in early pathological changes, but is likely involved in remodeling at the late stage. Both ECM accumulation and ROS induction contributed to continuing remodeling, hypertrophy and extensive interstitial fibrosis. We investigated the potential mechanism by which activates TIMP1 induction in RFP cardiac myocytes. TIMP1 was shown as a downstream target of NF-κB signaling in which TIMP1 induced by the activation of NF-κB signaling in cancer models [21, 22] or under UPR and ER stress [23]. Therefore, we performed the staining for NF-κB p65 subunit as an indicator of NF-κB activation in RFP+/+ cardiac myocytes and found an increase of p65 nuclear and perinuclear staining in cardiac myocytes (Figure (Figure5F).5F). Although a direct causal relation of NF-κB activation in RFP heart and TIMP1 induction was not shown by us, TIMP1 induction together with mitochondrial dysfunction, activation of collagen genes, and ROS production work in sync toward depositing ECM and precipitating hypertrophy.

Figure 5
Cardiac fibrosis in RFP mouse

Resistance to DsRed-induced proteinopathy in skeletal muscles

Because the CAGGS promoter expresses a high level of transgene in skeletal muscles, we turned to look into any skeletal phenotype in RFP mouse. Skeletal muscle of RFP mouse did not display signs of inflammation, darkened cytoplasm or interstitial fibrosis (Figure 6A, 6B). We thus speculated the amount of transgene expressed in the skeletal muscle or the degree of DsRed oligomerization to be different from that in cardiac muscle. However, the level of RFP expression in skeletal muscles and the amount of RFP oligomers were found very similar to cardiac muscle (Figure 6C, 6D). Accumulation of ubiquitinated proteins was absent in skeletal muscle, indicating a lack of proteinopathy (Figure (Figure6E).6E). In RFP mouse the level of p62, LC3B or LAMP-1 in skeletal tissues was not different from the wild-type mouse.

Figure 6
RFP aggregation in skeletal muscles without causing myopathy

Heart-specific tetrameric DsRed expression led to heart failure

We generated Myh6-CreERT2:;CALELD+/+ double-Tg mouse to achieve expressing DsRed transgene only in cardiac tissues (Figure (Figure7A)7A) to confirm our findings and exclude causes such as RFP accumulation in other organs that could have contributed to heart dysfunctions. Following the tamoxifen treatment (feeding mice with tamoxifen-containing chow for 2 weeks), severe respiratory stress was developed in double-Tg mice which had to be euthanized by 10 weeks after initiating tamoxifen diet (Figure (Figure7B).7B). Cardiac phenotypes including hypertrophy, left atrium thrombosis, and interstitial fibrosis were similar to those observed in the ubiquitous RFP mice. An increase of HW/BW and HW/TL ratios was resulted in tamoxifen-induced mice (Figure (Figure7C).7C). Because control Tg mice such as Myh6-CreERT2 mice or CALELD mice fed by tamoxifen-chow did not develop hypertrophy (data not shown) and that tamoxifen treatment was for only two weeks, tamoxifen by itself unlikely caused the heart failure. An increase of p62, LC3B, LAMP1 and TIMP1 proteins was found in tamoxifen-induced heart (Figure (Figure7D).7D). Similar dark spots by H&E staining and extensive interstitial collagen deposits were present in tamoxifen-induced double Tg mouse heart (Figure (Figure7E).7E). We observed a massive accumulation of ubiquitinated proteins including proteins with the ubiquitin attached at residue Lys-63 or Lys-48 (Figure (Figure7F),7F), indicating the ubiquitin-proteasome stress in affected heart. Taken together, the CV phenotypes induced by cardiac-specific RFP expression agree with RFP mouse and that DsRed tetramer aggregation in heart is sufficient to induce proteinopathy and congestive heart failure.

Figure 7
Heart failure resulted from cardiac-specific RFP expression

DISCUSSION

In this study, we generated the RFP mouse by recombining the transgene of CALELD mouse, which serves as an ideal control for the RFP mouse because the promoter, transgene copies, level of expression, and the location of genome insertion were the same for both mice. EGFP, which primarily forms monomers or dimers, is less toxic to the cells than DsRed. That a massive GFP expression led to hypertrophic and dilated heart failure in a transgene copy-dependent manner was previously reported [24], but we did not observe any CV phenotype in CALELD mice. One possible explanation is that the amount of EGFP expressed in CALELD mice is less than the previous model. EGFP that binds to the myosin and interrupts the cytoskeletal component has the potential to disrupt the contractile function of muscle cells [25]. The toxicity of EGFP aggregation was demonstrated by various cell culture models [2628], including that EGFP-induced toxicity was related to an inhibition of NFμB signaling and to a suppressed protein ubiquitination and degradation [27, 29, 30]. By using CALELD and RFP Tg mouse, we show protein ubiquitination not affected by EGFP and that RFP expression led to an increase, instead of a decrease, of protein ubiquitination in cardiac myocytes.

Tetrameric DsRed, one of early RFPs developed for molecular imaging applications, was replaced by newer monomeric RFPs. Tetrameric DsRed was reported to suppress Bcl-xL translation [14]. Previously, the toxicity of tetrameric DsRed to embryonic and hematopoietic stem cells prevented the generation of Tg mouse expressing DsRed tetramers [15, 31, 32]. The DsRed monomer Tg mice were later generated without any reported abnormalities [3234]. While the toxicity of DsRed tetramers in cell culture was known for a long time, without DsRed mice, the in vivo consequence by DsRed-elicited toxicity in whole body and a detailed pathological analysis was not previously feasible. In this work, we demonstrate for the first time in animal model the proteinopathy caused by aggregation of DsRed tetramers.

With the advance of technology for diagnoses and increasing awareness, heart diseases caused by proteinopathy are likely to increase in the future. Proteinopathy is the primary cause of senile cardiac amyloidosis and of certain congenital heart diseases such as desmin-related cardiomyopathy (DRC) [3537]. Phenotypes of RFP mouse including aggregation, inflammation, massive ubiquitinated proteins and DCM were consistent with phenotypes caused by chronic inhibition of autophagy or by defective proteasomal function [38, 39]. By analyzing the cardiac transcriptome at various ages and of various levels of expression, we found in RFP heart that genes with the most changes which correlate impressively with the severity of myopathy are groups of genes relating to cardiotoxicity (Table S1). RFP mouse displays histology features similar to that of amyloidosis or DRC. Heart sections of amyloidosis sometimes show typical apple-green birefringence under polarized light with Congo red staining. Fluorescent proteins contain abundant β-sheet structures, but we did not observe similar birefringence in RFP heart sections (data not shown) probably due to the nature of DsRed aggregates not stainable by Congo red.

Induction of p62/SQSTM1 and massive ubiquitinated proteins are the most noticed features in young RFP mouse heart. p62 is involved in both proteasome-mediated proteolysis and autophagosome/lysosome-mediated protein degradation [40]. Accumulation of p62 was commonly found in cardiac UPR or proteasome functional insufficiency (PFI) models that suggests a pivoting role by p62 in mediating UPR and PFI-induced myopathy [41]. The origins of p62 induction in proteinopathy may include an enhanced de novo p62 synthesis, an inhibition of autophagy that is responsible for p62 degradation, or by selective autophagy of damaged organelles and protein aggregates [42]. p62 induction in RFP heart can be addressed from two perspectives : (1) whereas p62 transcripts were moderately increased in both RFP+/+ and RFP+/− heart, p62 protein was not increased in RFP+/− heart. NRF2 signaling, which mediates p62 induction in other models was not induced in RFP heart. Thus, the increase of p62 protein in RFP+/+ heart was probably not due to an increase of de novo p62 synthesis as in other models [43]; (2) we expressed DsRed tetramers in H9C2 cells, a cell line of cardiac origin, and treated cells with chloroquine, which resulted a mild increase of p62 without enhanced protein ubiquitination. Treating cells with bortezomib, a proteasome inhibitor, resulted a strong p62 induction and accumulation of ubiquitinated proteins (data not shown). Thus, p62 induction in RFP heart likely resulted from proteasome stress such as under PFI or due to a reduction of autophagy. In our view, pathogenesis of RFP-induced proteinopathy likely involves both PFI and chronic autophagy/lysosome inhibition and the former likely plays a more important role. We showed the clustered RFP physically associated with ubiquitin, p62, LC3B, and with the MuRF1, which potentially utilized ubiquitin-tagged RFP as a substrate. Clustered RFP were frequently located close to the junctions that likely cause the interruption of contractility. MuRF1 mediates protein degradation at the vicinity of Z-disk, and increased expression of E3 ligases including MuRF1 and MAFbx was considered as markers of muscle atrophy [44, 45]. UPS activation and MuRF1 induction in RFP+/+ heart potentially could trigger an atrophic response, leading to a loss of myocytes, which were subsequently replaced by fibrotic tissues.

Containing similar levels of DsRed aggregation as in cardiac tissues, skeletal muscles tolerate DsRed-induced proteinopathy, and some RFP+/− mice were free of skeletal symptoms throughout the life span of at least 18 months. One explanation for cardiac cells particularly vulnerable to proteinopathy is in that higher oxidative stress experienced by cardiac cells may be a crucial cofactor in producing damages in proteasomes [46]. Other explanations also exist, such as skeletal muscle can tolerate the protein toxicity and myocyte loss due to a better renewal capability than cardiac myocytes.

Most experimental models of cardiac interstitial fibrosis usually develop fibrotic tissues preferentially at the epicardium, endocardium or perivascular regions [4751]. In contrast, fibrotic deposits were extensively distributed in RFP mouse with the most severe fibrosis occurred in myocardium, suggesting that interstitial fibrosis caused by RFP may result from a distinct mechanism which potentially involves the mechanical loading as a precipitating factor.

Hypertrophy and DCM as myocardial maladaptation to the pathological stress can be induced by a tilted balance between MMPs and TIMPs [5254]. Elevated MMP2, TIMP1, collagen type I and III levels were reported in patients with hypertrophy and heart failure [5557]. Collagen expression and TIMP1 induction in RFP heart correlated strongly with transgene dosage and severity of the disease. The changes in MMP levels except for MMP2 or MMP9 were relatively mild, strongly agreeable with those clinical reports and the net balance between TIMPs and MMPs favored ECM deposition. TIMP1 induction started in young RFP mouse heart and continuing activation suggests the potential of TIMP1 as a biomarker for detecting early stage cardiac fibrosis. We identified NF-κB activation and an increase of markers for UPR and ER stress in RFP heart, consistent with previous reports showing NF-κB activation in cardiac myopathy involving ER stress and UPR [58, 59]. TIMP1 induction in RFP heart may involve NF-κB signaling, but to clarify TIMP1 induced directly by NF-κB requires further study. RFP-induced cardiac dysfunctions suggest an important role of the autophagy lysosomal pathway mediating hypertrophy and fibrosis. This is in line with reports showing therapeutic potential to control tissue fibrosis and other aging-related diseases by modulating autophagy pathways and with reports on established roles of mTOR (mammalian target of rapamycin) in regulating protein synthesis, cell proliferation, immune cell activation, and autophagy [6062]. Inhibition of mTOR with rapamycin or by inhibitors at its upstream or downstream signaling pathways were shown to reduce interstitial fibrosis [60, 63]. Thus, our future work will try to amend the cardiac myopathy in RFP mice by rapamycin or rapalogs.

In summary, main findings of this study include the following: (1) transgenic expression of tetrameric DsRed caused myocardial injury, fibrosis and heart failure in RFP mouse. S of RFP mouse contained comparable levels of aggregates as in cardiac tissues, but remained symptom free; (2) RFP aggregates increased the loading to the UPS and the ALS and ultimately resulted both systems overloaded with pathology appearance similar to that of PFI and of chronic ALS inhibition. Other pathology features include the accumulation of residual bodies, mitochondrial dysfunction, and ROS production that leads to myocyte injury and death; and (3) cell injury and necrosis triggers inflammation and TIMP1 induction, leading to massive interstitial fibrosis, pathological hypertrophy, and DCM. Our working hypothesis for the heart failure in RFP mouse is summarized in Figure Figure8.8. Taken together, we demonstrate here the RFP mouse as a model of proteinopathy-induced DCM. This model can be used as a platform for in vivo testing of new pharmaceuticals and/or for developing the novel treatment of senile cardiac diseases.

Figure 8
Working hypothesis for the mechanism of interstitial fibrosis and heart failure caused by RFP aggregates

MATERIALS AND METHODS

Transgenic mice

Generation of FVB/NJ CAGGS-LoxP-EGFP-LoxP-DsRed (CALELD) and Cre transgenic mice has been described previously [64, 65]. Myh6-creERT2 transgenic mice were obtained from the Jackson laboratory (Bar Harbor, ME, USA). CALELD mice were crossed to Cre mice to generate DsRed-expressing mice. Heterozygous or homozygous RFP mice without the Cre allele were subsequently generated. CALELD mice and Myh6-creERT2 mice were used to obtain a double-Tg mouse. A tamoxifen diet (LAS TAM400, LASvendi, Germany) for two weeks was used to induce recombination. Tail DNA was purified using an Allele-In-One Mouse Tail Direct PCR System kit (Allele Biotech, San Diego, USA). For the CALELD allele, the forward and reverse primers were 5′-CTGCTAACCATGTTCATGCC-3′ and 5′-GTACTGGAACTGGG GGGACAG-3′. For the DsRed allele, the forward and reverse primers were 5′-CTGCTAACCATGTTCATGCC-3′ and 5′-GATCTGGAACTGGGGGGACAG-3′. All animal experiments were conducted by conforming to the NIH guideline (Guide for the care and use of laboratory animals) and approved by National Health Research Institutes, Taiwan [NHRI-IACUC-099011A, NHRI-IACUC-100124A].

Additional Materials and Methods can be found in the Supplemental Data.

Statistics

All values are expressed as the mean ± standard error mean (SEM). Data were analyzed using the Student's t-test and P < 0.05 was considered significant.

SUPPLEMENTARY MATERIALS FIGURES AND TABLES

Acknowledgments

We thank Dr. Chung-Shi Yang at I-BEN at National Health Research Institutes (NHRI), and Institute of Molecular Biology, Academia Sinica of Taiwan for providing Hitachi-H7650 EM and FEI Tecnai G2 spirit EM facility. We thank Shu-Feng Hu at NOBC, NHRI for the assistance on confocal microscopy. We gratefully appreciate suggestions provided by Drs. Chun-Hong Chen, Liang-Tung Yang, and Wayne Chang of NHRI.

Footnotes

CONFLICTS OF INTEREST

All authors declare no financial conflict of interests relating to the submitted manuscript.

GRANT SUPPORT

This work was supported by grants from NHRI [BNPP02] [BNPP024] and from the Ministry of Science and Technology of Taiwan [MOST103-2320B400-018], [MOST104-2314B400-008],[NSC100-2314B400-006].

Editorial note

This paper has been accepted based in part on peer-review conducted by another journal and the authors' response and revisions as well as expedited peer-review in Oncotarget.

REFERENCES

1. Willis MS, Patterson C. Proteotoxicity and cardiac dysfunction—Alzheimer's disease of the heart? The New England Journal of Medicine. 2013;368:455–464. [PubMed]
2. Pattison JS, Robbins J. Protein misfolding and cardiac disease: establishing cause and effect. Autophagy. 2008;4:821–823. [PMC free article] [PubMed]
3. McLendon PM, Robbins J. Proteotoxicity and Cardiac Dysfunction. Circulation Research. 2015;116:1863–1882. [PMC free article] [PubMed]
4. Ebrahimi-Fakhari D, McLean PJ, Wahlster L. Proteotoxicity and cardiac dysfunction. The New England Journal of Medicine. 2013;368:1754. [PubMed]
5. Galli A. Proteotoxicity and cardiac dysfunction. The New England Journal of Medicine. 2013;368:1754–1755. [PubMed]
6. Wang X, Robbins J. Heart failure and protein quality control. Circulation Research. 2006;99:1315–1328. [PubMed]
7. Chen B, Retzlaff M, Roos T, Frydman J. Cellular strategies of protein quality control. Cold Spring Harbor Perspectives in Biology. 2011;3:a004374. [PMC free article] [PubMed]
8. Wang ZV, Hill JA. Protein quality control and metabolism: bidirectional control in the heart. Cell Metabolism. 2015;21:215–226. [PMC free article] [PubMed]
9. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends in Cardiovascular Medicine. 2009;19:247–252. [PubMed]
10. Sorokin L. The impact of the extracellular matrix on inflammation. Nature Reviews Immunology. 2010;10:712–723. [PubMed]
11. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, 3rd, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 1998;97:1708–1715. [PubMed]
12. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circulation Research. 2002;90:520–530. [PubMed]
13. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102:1944–1949. [PubMed]
14. Zhou J, Lin J, Zhou C, Deng X, Xia B. Cytotoxicity of red fluorescent protein DsRed is associated with the suppression of Bcl-xL translation. FEBS Letters. 2011;585:821–827. [PubMed]
15. Hadjantonakis AK, Macmaster S, Nagy A. Embryonic stem cells and mice expressing different GFP variants for multiple non-invasive reporter usage within a single animal. BMC Biotechnology. 2002;2:11. [PMC free article] [PubMed]
16. Gottlieb RA, Andres AM, Sin J, Taylor DP. Untangling autophagy measurements: all fluxed up. Circulation Research. 2015;116:504–514. [PMC free article] [PubMed]
17. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN, Kim L, Gottlieb RA. A method to measure cardiac autophagic flux in vivo. Autophagy. 2008;4:322–329. [PMC free article] [PubMed]
18. Sun Y, Weber KT. Animal models of cardiac fibrosis. Methods in Molecular Medicine. 2005;117:273–290. [PubMed]
19. Gurtl B, Kratky D, Guelly C, Zhang L, Gorkiewicz G, Das SK, Tamilarasan KP, Hoefler G. Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy. International Journal of Experimental Pathology. 2009;90:338–346. [PubMed]
20. Gay-Jordi G, Guash E, Benito B, Brugada J, Nattel S, Mont L, Serrano-Mollar A. Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS One. 2013;8:e55427. [PMC free article] [PubMed]
21. Oh WK, Vargas R, Jacobus S, Leitzel K, Regan MM, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali SM, Kantoff PW, Lipton A. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer. 2011;117:517–525. [PubMed]
22. Bommarito A, Richiusa P, Carissimi E, Pizzolanti G, Rodolico V, Zito G, Criscimanna A, Di Blasi F, Pitrone M, Zerilli M, Amato MC, Spinelli G, Carina V, Modica G, Latteri MA, Galluzzo A, et al. BRAFV600E mutation, TIMP-1 upregulation, and NF-kappaB activation: closing the loop on the papillary thyroid cancer trilogy. Endocrine-Related Cancer. 2011;18:669–685. [PubMed]
23. Wilczynska KM, Gopalan SM, Bugno M, Kasza A, Konik BS, Bryan L, Wright S, Griswold-Prenner I, Kordula T. A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes. The Journal of Biological Chemistry. 2006;281:34955–34964. [PubMed]
24. Huang WY, Aramburu J, Douglas PS, Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nature Medicine. 2000;6:482–483. [PubMed]
25. Agbulut O, Coirault C, Niederlander N, Huet A, Vicart P, Hagege A, Puceat M, Menasche P. GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy. Nature Methods. 2006;3:331. [PubMed]
26. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochemical and Biophysical Research Communications. 1999;260:712–717. [PubMed]
27. Baens M, Noels H, Broeckx V, Hagens S, Fevery S, Billiau AD, Vankelecom H, Marynen P. The dark side of EGFP: defective polyubiquitination. PLoS One. 2006;1:e54. [PMC free article] [PubMed]
28. Choi WG, Swanson SJ, Gilroy S. High-resolution imaging of Ca2+, redox status, ROS and pH using GFP biosensors. The Plant Journal. 2012;70:118–128. [PubMed]
29. Zhang F, Hackett NR, Lam G, Cheng J, Pergolizzi R, Luo L, Shmelkov SV, Edelberg J, Crystal RG, Rafii S. Green fluorescent protein selectively induces HSP70-mediated up-regulation of COX-2 expression in endothelial cells. Blood. 2003;102:2115–2121. [PubMed]
30. Ran R, Lu A, Zhang L, Tang Y, Zhu H, Xu H, Feng Y, Han C, Zhou G, Rigby AC, Sharp FR. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes & Development. 2004;18:1466–1481. [PubMed]
31. Tao W, Evans BG, Yao J, Cooper S, Cornetta K, Ballas CB, Hangoc G, Broxmeyer HE. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells. 2007;25:670–678. [PubMed]
32. Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis. 2004;40:241–246. [PubMed]
33. Long JZ, Lackan CS, Hadjantonakis AK. Genetic and spectrally distinct in vivo imaging: embryonic stem cells and mice with widespread expression of a monomeric red fluorescent protein. BMC Biotechnology. 2005;5:20. [PMC free article] [PubMed]
34. Chou CJ, Peng SY, Wan CH, Chen SF, Cheng WT, Lin KY, Wu SC. Establishment of a DsRed-monomer-harboring ICR transgenic mouse model and effects of the transgene on tissue development. The Chinese Journal of Physiology. 2015;58:27–37. [PubMed]
35. McLendon PM, Robbins J. Desmin-related cardiomyopathy: an unfolding story. American Journal of Physiology Heart and Circulatory Physiology. 2011;301:H1220–1228. [PubMed]
36. Zheng Q, Su H, Ranek MJ, Wang X. Autophagy and p62 in cardiac proteinopathy. Circulation Research. 2011;109:296–308. [PMC free article] [PubMed]
37. Schmidt AP, Bohmer AE, Antunes C, Schallenberger C, Porciuncula LO, Elisabetsky E, Lara DR, Souza DO. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. British Journal of Pharmacology. 2009;156:163–172. [PMC free article] [PubMed]
38. Su H, Wang X. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovascular Research. 2010;85:253–262. [PMC free article] [PubMed]
39. Schlossarek S, Frey N, Carrier L. Ubiquitin-proteasome system and hereditary cardiomyopathies. Journal of Molecular and Cellular Cardiology. 2014;71:25–31. [PubMed]
40. Lilienbaum A. Relationship between the proteasomal system and autophagy. International Journal of Biochemistry and Molecular Biology. 2013;4:1–26. [PMC free article] [PubMed]
41. Su H, Wang X. p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends in Cardiovascular Medicine. 2011;21:224–228. [PMC free article] [PubMed]
42. Tian Z, Wang C, Hu C, Tian Y, Liu J, Wang X. Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes. PLoS One. 2014;9:e100715. [PMC free article] [PubMed]
43. Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Molecular Cell. 2013;51:618–631. [PubMed]
44. Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. American Journal of Physiology Endocrinology and Metabolism. 2014;307:E469–484. [PubMed]
45. Baehr LM, Furlow JD, Bodine SC. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. The Journal of Physiology. 2011;589:4759–4776. [PubMed]
46. Aiken CT, Kaake RM, Wang X, Huang L. Oxidative stress-mediated regulation of proteasome complexes. Molecular & Cellular Proteomics. 2011;10:R110. 006924. [PMC free article] [PubMed]
47. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. The Journal of Endocrinology. 1999;160:43–47. [PMC free article] [PubMed]
48. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849–1865. [PubMed]
49. Ichihara S, Senbonmatsu T, Price E, Jr, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 2001;104:346–351. [PubMed]
50. Ogata J, Fujishima M, Morotomi Y, Omae T. Cerebral infarction following bilateral carotid artery ligation in normotensive and spontaneously hypertensive rats: a pathological study. Stroke. 1976;7:54–60. [PubMed]
51. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010;2:914–23. doi: 10.18632/aging.100252. [PMC free article] [PubMed] [Cross Ref]
52. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension. 2002;40:136–141. [PubMed]
53. Rutschow S, Li J, Schultheiss HP, Pauschinger M. Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovascular Research. 2006;69:646–656. [PubMed]
54. Ikonomidis JS, Hendrick JW, Parkhurst AM, Herron AR, Escobar PG, Dowdy KB, Stroud RE, Hapke E, Zile MR, Spinale FG. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition. American Journal of Physiology Heart and Circulatory Physiology. 2005;288:H149–158. [PubMed]
55. Agrinier N, Thilly N, Boivin JM, Dousset B, Alla F, Zannad F. Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study. Fundamental & Clinical Pharmacology. 2013;27:572–580. [PubMed]
56. Barton PJ, Birks EJ, Felkin LE, Cullen ME, Koban MU, Yacoub MH. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. The Journal of Heart and Lung Transplantation. 2003;22:738–744. [PubMed]
57. Polyakova V, Loeffler I, Hein S, Miyagawa S, Piotrowska I, Dammer S, Risteli J, Schaper J, Kostin S. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. International Journal of Cardiology. 2011;151:18–33. [PubMed]
58. Minamino T, Komuro I, Kitakaze M. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circulation Research. 2010;107:1071–1082. [PubMed]
59. Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circulation Research. 2012;110:174–189. [PMC free article] [PubMed]
60. Liang S, Salas T, Gencaslan E, Li B, Habib SL. Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients. Oncotarget. 2014;5:6936–6946. doi: 10.18632/oncotarget.2206. [PMC free article] [PubMed] [Cross Ref]
61. Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 2012;181:278–293. [PubMed]
62. Hillel AT, Gelbard A. Unleashing rapamycin in fibrosis. Oncotarget. 2015;6:15722–15723. doi: 10.18632/oncotarget.4652. [PMC free article] [PubMed] [Cross Ref]
63. Blagosklonny MV. Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR. Cell Death & Disease. 2010;1:e12. [PMC free article] [PubMed]
64. Lin HY, Kao CH, Lin KM, Kaartinen V, Yang LT. Notch signaling regulates late-stage epidermal differentiation and maintains postnatal hair cycle homeostasis. PLoS One. 2011;6:e15842. [PMC free article] [PubMed]
65. Chen MR, Liu SW, Wu TC, Kao VY, Yu HC, Chen FH, Hsu CH, Chen CT, Lin KM. RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice. Genesis. 2010;48:585–595. [PubMed]

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC